About Posterior-predominant lissencephaly-broad flat pons and medulla-midline crossing defects syndrome
Posterior-predominant lissencephaly-broad flat pons and medulla-midline crossing defects syndrome is a rare disease catalogued by Orphanet (ORPHA:572013). It is associated with the MACF1, CEP85L genes. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Posterior-predominant lissencephaly-broad flat pons and medulla-midline crossing defects syndrome trials.
Search ClinicalTrials.gov for "Posterior-predominant lissencephaly-broad flat pons and medulla-midline crossing defects syndrome" or filter by Orphanet code ORPHA:572013 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Posterior-predominant lissencephaly-broad flat pons and medulla-midline crossing defects syndrome trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Posterior-predominant lissencephaly-broad flat pons and medulla-midline crossing defects syndrome. Updated daily.